Mitra Heravi
Overview
Explore the profile of Mitra Heravi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghashghaei M, Niazi T, Heravi M, Bekerat H, Trifiro M, Paliouras M, et al.
Prostate
. 2017 Nov;
78(1):64-75.
PMID: 29134684
Background: Prostate cancer (PCa) is a progressive disease and the most diagnosed cancer in men. The current standard of care for high-risk localized PCa is a combination of androgen deprivation...
2.
Maria O, Kumala S, Heravi M, Syme A, Eliopoulos N, Muanza T
Cytotherapy
. 2016 Jan;
18(3):384-401.
PMID: 26780866
Background Aims: This study evaluates the biological response of adipose tissue-derived mesenchymal stromal cells (aMSCs) to ionizing radiation (IR). Methods: Irradiated BALB/c mice aMSCs were characterized for functionality and phenotype....
3.
Heravi M, Kumala S, Rachid Z, Jean-Claude B, Radzioch D, Muanza T
Int J Radiat Oncol Biol Phys
. 2015 Apr;
92(2):399-406.
PMID: 25823448
Purpose: ZRBA1 is a combi-molecule designed to induce DNA alkylating lesions and to block epidermal growth factor receptor (EGFR) TK domain. Inasmuch as ZRBA1 downregulates the EGFR TK-mediated antisurvival signaling...
4.
Heravi M, Tomic N, Liang L, Devic S, Holmes J, DeBlois F, et al.
Anticancer Drugs
. 2012 Feb;
23(5):525-33.
PMID: 22357220
High expression of vascular endothelial growth factor (VEGF) in patients with breast cancer has been associated with a poor prognosis, indicating that VEGF could be linked to the efficacy of...
5.
Xu Y, Heravi M, Thuraisingam T, Di Marco S, Muanza T, Radzioch D
Mol Cancer
. 2010 Aug;
9:210.
PMID: 20687958
Background: Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either...
6.
Thuraisingam T, Xu Y, Eadie K, Heravi M, Guiot M, Greemberg R, et al.
J Invest Dermatol
. 2009 Jul;
130(1):278-86.
PMID: 19609314
Cutaneous wound healing is a complex process, which is heavily dependent on successful inflammatory action. Mitogen-activated protein kinase (MAPK)-activated protein kinase-2 (MAPKAPK-2 or MK2), a major substrate of p38 MAPK,...
7.
Heravi M, Rachid Z, Goudarzi A, Schlisser A, Jean-Claude B, Radzioch D, et al.
Anticancer Drugs
. 2009 Jul;
20(8):659-67.
PMID: 19581798
ZRBA1 is a molecule termed 'combi-molecule' designed to induce DNA-alkylating lesions and to block epidermal growth factor receptor (EGFR) tyrosine kinase. Owing to its ability to downregulate the EGFR tyrosine...